Asset Details
Do you wish to reserve the book?
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
Do you wish to request the book?
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells
2004
Overview
Cyclin B1 is the regulatory subunit of M-phase promoting factor, and proper regulation of cyclin B1 is essential for the initiation of mitosis. Increasing evidence indicates that the deregulation of cyclin B1 is involved in neoplastic transformation, suggesting the suppression of cyclin B1 could be an attractive strategy for antiproliferative therapy. In the present work, we analysed the impact of small interfering RNAs (siRNAs) targeted to cyclin B1 on different human tumor cell lines. Cyclin B1 siRNAs reduced the protein level of cyclin B1 in HeLa, MCF-7, BT-474 and MDA-MB-435 tumor cells and efficiently reduced the kinase activity of Cdc2/cyclin B1 in HeLa cells. siRNA-treated cells were arrested in G2/M phase in all tumor cell lines tested. Proliferation of tumor cells from different origins was suppressed by 50–80% 48 h after transfection and apoptosis was increased from 5 to 40–50%. Furthermore, tumor cells showed less colony-forming ability after siRNA treatment. In contrast, primary human umbilical vein endothelial cells exhibited only a slight change in cell cycle, and neither apoptosis nor clear inhibition of proliferation was observed after cyclin B1 siRNA treatment for 48 h. These results indicate that siRNAs against cyclin B1 could become a powerful antiproliferative tool in future antitumor therapy.
Publisher
Nature Publishing Group UK,Nature Publishing,Nature Publishing Group
Subject
/ Biological and medical sciences
/ Breast Neoplasms - drug therapy
/ Breast Neoplasms - pathology
/ Cancer
/ CDC2 Protein Kinase - drug effects
/ CDC2 Protein Kinase - metabolism
/ Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes
/ Female
/ Fundamental and applied biological sciences. Psychology
/ Humans
/ Kinases
/ Maturation-Promoting Factor - drug effects
/ Maturation-Promoting Factor - metabolism
/ Medicine
/ Mitosis
/ Molecular and cellular biology
/ Oncology
/ Proteins
/ RNA, Small Interfering - pharmacology
/ siRNA
